Megan Prictor

Dr. Megan Prictor

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2014 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
RRRebecca Emily Ryan
Rebecca Emily Ryan
NSNancy Santesso
Nancy Santesso
DLDianne Lowe
Dianne Lowe
SHSophie Hill
Sophie Hill
JGJeremy Grimshaw
Jeremy Grimshaw
MTMichael Taylor
Michael Taylor

28 March 2013 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
VPVeronica Pitt
Veronica Pitt
DLDianne Lowe
Dianne Lowe
SHSophie Hill
Sophie Hill
MPMegan Prictor
Megan Prictor
SHSarah E Hetrick
Sarah E Hetrick
LBLynda Berends
Lynda Berends

9 May 2014 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
ASAnneliese Synnot
Anneliese Synnot
RRRebecca Ryan
Rebecca Ryan
MPMegan Prictor
Megan Prictor
DFDeirdre Fetherstonhaugh
Deirdre Fetherstonhaugh
BPBarbara Parker
Barbara Parker

28 November 2020 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
HTHarriet J. A. Teare
Harriet J. A. Teare
MPMegan Prictor
Megan Prictor
JKJane Kaye
Jane Kaye
Dynamic consent (DC) was originally developed in response to challenges to the informed consent process presented by participants agreeing to ‘future research’ in biobanking. In the past 12 years, it has been trialled in a number of different projects, and examined as a new approach for consent and to support patient engagement over time. There have been significant societal shifts during this time, namely in our reliance on digital tools and the use of social media, as well as a greater appreciation of the integral role of patients in biomedical research. This paper reflects on the development of DC to understand its importance in an age where digital health is becoming the norm and patients require greater oversight and control of how their data may be used in a range of settings. As well as looking back, it looks forwards to consider how DC could be further utilised to enhance the patient experience and address some of the inequalities caused by the digital divide in society.

4 May 2022 in Journal of Medical Internet Research
Verified
Journal Article
Open access
TKTimothy Charles Kariotis
Timothy Charles Kariotis
MPMegan Prictor
Megan Prictor
SCShanton Chang
Shanton Chang
KGKathleen Gray
Kathleen Gray
Background: The adoption of electronic health records (EHRs) and electronic medical records (EMRs) has been slow in the mental health context, partly because of concerns regarding the collection of sensitive information, the standardization of mental health data, and the risk of negatively affecting therapeutic relationships. However, EHRs and EMRs are increasingly viewed as critical to improving information practices such as the documentation, use, and sharing of information and, more broadly, the quality of care provided. Objective: This paper aims to undertake a scoping review to explore the impact of EHRs on information practices in mental health contexts and also explore how sensitive information, data standardization, and therapeutic relationships are managed when using EHRs in mental health contexts. Methods: We considered a scoping review to be the most appropriate method for this review because of the relatively recent uptake of EHRs in mental health contexts. A comprehensive search of electronic databases was conducted with no date restrictions for articles that described the use of EHRs, EMRs, or associated systems in the mental health context. One of the authors reviewed all full texts, with 2 other authors each screening half of the full-text articles. The fourth author mediated the disagreements. Data regarding study characteristics were charted. A narrative and thematic synthesis approach was taken to analyze the included studies’ results and address the research questions. Results: The final review included 40 articles. The included studies were highly heterogeneous with a variety of study designs, objectives, and settings. Several themes and subthemes were identified that explored the impact of EHRs on information practices in the mental health context. EHRs improved the amount of information documented compared with paper. However, mental health–related information was regularly missing from EHRs, especially sensitive information. EHRs introduced more standardized and formalized documentation practices that raised issues because of the focus on narrative information in the mental health context. EHRs were found to disrupt information workflows in the mental health context, especially when they did not include appropriate templates or care plans. Usability issues also contributed to workflow concerns. Managing the documentation of sensitive information in EHRs was problematic; clinicians sometimes watered down sensitive information or chose to keep it in separate records. Concerningly, the included studies rarely involved service user perspectives. Furthermore, many studies provided limited information on the functionality or technical specifications of the EHR being used. Conclusions: We identified several areas in which work is needed to ensure that EHRs benefit clinicians and service users in the mental health context. As EHRs are increasingly considered critical for modern health systems, health care decision-makers should consider how EHRs can better reflect the complexity and sensitivity of information practices and workflows in the mental health context.

5 September 2018 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
MPMegan Prictor
Megan Prictor
HTHarriet J. A. Teare
Harriet J. A. Teare
JKJane Kaye
Jane Kaye
Participation in biobanks tends to favor certain groups—white, middle-class, more highly-educated—often to the exclusion of others, such as indigenous people, the socially-disadvantaged and the culturally and linguistically diverse. Barriers to participation, which include age, location, cultural sensitivities around human tissue, and issues of literacy and language, can influence the diversity of samples found in biobanks. This has implications for the generalizability of research findings from biobanks being able to be translated into the clinic. Dynamic Consent, which is a digital decision-support tool, could improve participants' recruitment to, and engagement with, biobanks over time and help to overcome some of the barriers to participation. However, there are also risks that it may deepen the “digital divide” by favoring those with knowledge and access to digital technologies, with the potential to decrease participant engagement in research. When applying a Dynamic Consent approach in biobanking, researchers should give particular attention to adaptations that can improve participant inclusivity, and evaluate the tool empirically, with a focus on equity-relevant outcome measures. This may help biobanks to fulfill their promise of enabling translational research that is relevant to all.